Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Issues regarding gene therapy products for Parkinson's disease: the development of CERE-120 (AAV-NTN) as one reference point.

Authors
Type
Published Article
Journal
Parkinsonism & Related Disorders
1353-8020
Publisher
Elsevier
Publication Date
Volume
13 Suppl 3
Identifiers
DOI: 10.1016/S1353-8020(08)70052-X
PMID: 18267286
Source
Medline

Abstract

Statistics

Seen <100 times